CD8A and neoplasm: in 2018(60) validated the prognostic value of the consensus Immunoscore, which summarizes the density of CD3+ and CD8+ effector T-cells within the tumor and its invasive margin by converting the CD3+ and CD8+ cell densities in these regions to percentiles.